@article{CJCR1523,
author = {Wei-ben Yong and Yun-tao Zhang and Wen Zheng and Yan Wei and Jun Zhu},
title = {THERAPEUTIC EFFICACY OF L-ASPARAGINASE IN THE TREATMENT OF REFRACTORY MIDFACIAL PERIPHERAL T-CELL NON-HODGKIN'S LYMPHOMA},
journal = {Chinese Journal of Cancer Research},
volume = {12},
number = {3},
year = {2013},
keywords = {},
abstract = {Objective: To improve the efficacy of refractory midfacial peripheral T-cell non-Hodgkin's lymphoma (MPTC-NHL) with L-asparaginase (L-ASP) based salvage chemotherapy.
Methods: 21 patients with refractory MPTC-NHL were analyzed, llpatients (L-ASP group) received L-asparaginase based salvage chemotherapy consisting of L-asparaginase, vincristine and dexamethosone. 10 patients (control group) received salvage combination chemotherapy without L-asparaginase.
Results: Complete remission rates were 45.6% for L-ASP group and 0.0% for control group (P},
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/1523}
}